Skin Cancer Drug, will be launched

Skin Cancer Drug, will be launched - Yervoy or ipilimumab, drugs to overcoome the melanoma, the deadliest skin cancer, was approved by the Food and Drug Administration (FDA). Previous primary melanoma therapy is removal of the tumor through surgery.

Melanoma usually arises from pigment-producing skin cells (melanin) and do not cause pain. UV radiation is a major cause of melanoma. Certain types of moles can turn into melanoma.

According to FDA data, in 2020 in the United States found 68,130 patients who are diagnosed with melanoma and 8,700 people of whom died.

Yervoy work to hold a molecule called CTLA-4, which is believed to weaken the immune system, so the body's ability to fight cancer disrupted.

Drug production Bristol-Myers Squibb has been evaluated against 676 clinical melanoma patients whose cancer has spread, or can not be dissected again. All patients noted to respond to other types of melanoma therapy that also approved by FDA.